UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
|
September 27, 2004 | |
Pharmion Corporation
| Delaware | 000-50447 | 84-1521333 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 2525 28th Street, Boulder, Colorado | 80301 | |
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code | 720-564-9100 | |
| Item 2.02 | Financial Statements, Pro Forma Financial Information and Exhibits |
(c) Exhibit 99.1 — Press Release dated September 27, 2004.
This exhibit is furnished pursuant to Item 12 and shall not be deemed to be “filed.”
| Item 9.01 | Disclosure of Results of Operations and Financial Condition |
On September 27, 2004, the Pharmion Corporation issued a press release updating the Company’s 2004 sales and earnings guidance. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHARMION CORPORATION |
||||
| Date: 9-27-04 | By: | /s/ Erle T. Mast | ||
| Erle T. Mast | ||||
| Chief Financial Officer | ||||
2
EXHIBIT INDEX
| Exhibit No. | Description | |
99.1
|
Press release dated September 27, 2004 updating the Company’s 2004 sales and earnings guidance. |
3